UBS’s iBio IBIO Stock Holding History

UBS’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$2K	Sell	1 -9	-90%	-$22K	﹤0.01%	9988
2014 Q2	$20K	Buy	10 +8	+400%	+$17.3K	﹤0.01%	8077
2014 Q1	$6K	Buy	2 +1	+100%	+$2.67K	﹤0.01%	9374
2013 Q4	$2K	Hold	1	–	–	﹤0.01%	10032
2013 Q3	$2K	Sell	1 -4	-80%	-$9.56K	﹤0.01%	9951
2013 Q2	$10K	Buy	+5	New	+$11.5K	﹤0.01%	8621

Other funds holding IBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GHA

GW Henssler & Associates Kennesaw, Georgia $2.12B AUM 20.77% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TDC

Thompson Davis & Co Richmond, Virginia $150M AUM 32.35% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

UBS's IBIO Position: Q3 2014 in Review

UBS reduced its iBio (IBIO) stake by 90% in Q3 2014, selling an estimated $22K and leaving 1 share worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #9988.

UBS first reported a position in IBIO in Q2 2013 and has held it in 6 quarters since. The position peaked at $20K in Q2 2014. 9 funds tracked by Wall St. Rank hold IBIO as of Q3 2014.

UBS held 1 share of iBio worth $2K as of Q3 2014.
UBS sold 9 iBio shares in Q3 2014, an estimated $22K.
iBio made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9988 holding.
UBS first reported a position in iBio in Q2 2013 and has held it in 6 quarters since.
UBS's iBio position peaked at $20K in Q2 2014.
9 funds tracked by Wall St. Rank held iBio as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.